Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China · Delayed Price · Currency is CNY 7.42
-0.02 (-0.27%)
Aug 4, 2026, 3:00 PM CST
Cabio Biotech (Wuhan) Market Cap
Cabio Biotech (Wuhan) has a market cap or net worth of 1.22 billion as of August 4, 2026. Its market cap has decreased by -73.41% in one year.
Market Cap
1.22B
Enterprise Value
1.05B
Revenue
418.18M
Ranking
n/a
PE Ratio
22.51
Stock Price
7.42
ChartMarket Cap Chart
Since December 19, 2019, Cabio Biotech (Wuhan)'s market cap has decreased from 5.54B to 1.22B, a decrease of -77.97%. That is a compound annual growth rate of -20.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 1.22B | -68.57% |
| Dec 31, 2025 | 3.88B | 21.24% |
| Dec 31, 2024 | 3.20B | 6.31% |
| Dec 29, 2023 | 3.01B | -44.60% |
| Dec 30, 2022 | 5.44B | -26.24% |
| Dec 31, 2021 | 7.37B | 55.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding